Peking University Cancer Hospital & Institute
Peking University Cancer Hospital & Institute
Beijing, Beijing Municipality, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors | Malignant Solid Tumors | Recruiting | Early phase 1 | 2024-05-14 | NCT05579275 |